Chantel Moret

Summary

Affiliation: NeuroBiz Consulting and Communications
Country: France

Publications

  1. ncbi request reprint Where are the new therapies for anxiety and obsessive-compulsive disorders?
    C Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    IDrugs 4:1031-42. 2001
  2. pmc Combination/augmentation strategies for improving the treatment of depression
    Chantal Moret
    NeuroBiz Consulting and Communications, Castres, France
    Neuropsychiatr Dis Treat 1:301-9. 2005
  3. pmc Antidepressants in the treatment of fibromyalgia
    Chantal Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    Neuropsychiatr Dis Treat 2:537-48. 2006
  4. pmc The importance of norepinephrine in depression
    Chantal Moret
    NeuroBiz Consulting and Communication, Castres, France
    Neuropsychiatr Dis Treat 7:9-13. 2011
  5. ncbi request reprint The role and therapeutic potential of 5-HT-moduline in psychiatry
    Chantal Moret
    NeuroBiz Consulting and Communications, Castres, France
    Semin Clin Neuropsychiatry 8:137-46. 2003
  6. ncbi request reprint Impact of gene polymorphisms on depression and its treatment
    Chantel Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    IDrugs 7:558-62. 2004
  7. doi request reprint Problems associated with long-term treatment with selective serotonin reuptake inhibitors
    C Moret
    NeuroBiz Consulting and Communication, Castres, France
    J Psychopharmacol 23:967-74. 2009

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Where are the new therapies for anxiety and obsessive-compulsive disorders?
    C Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    IDrugs 4:1031-42. 2001
    ..The challenge for the future is not only to find efficacious treatments with a rapid onset of action and an acceptable side effect profile but also to determine the optimal compounds for each of the different anxiety disorders...
  2. pmc Combination/augmentation strategies for improving the treatment of depression
    Chantal Moret
    NeuroBiz Consulting and Communications, Castres, France
    Neuropsychiatr Dis Treat 1:301-9. 2005
    ..This article reviews the various strategies adopted by clinicians in the hope of increasing the response rate of current antidepressants to obtain full remission and/or to overcome treatment-resistant depression...
  3. pmc Antidepressants in the treatment of fibromyalgia
    Chantal Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    Neuropsychiatr Dis Treat 2:537-48. 2006
    ..The effectiveness of antidepressants appears to be independent of their effect on comorbid depression...
  4. pmc The importance of norepinephrine in depression
    Chantal Moret
    NeuroBiz Consulting and Communication, Castres, France
    Neuropsychiatr Dis Treat 7:9-13. 2011
    ..Social dysfunction is possibly one of the most important factors affecting the quality of life in depressed patients...
  5. ncbi request reprint The role and therapeutic potential of 5-HT-moduline in psychiatry
    Chantal Moret
    NeuroBiz Consulting and Communications, Castres, France
    Semin Clin Neuropsychiatry 8:137-46. 2003
    ....
  6. ncbi request reprint Impact of gene polymorphisms on depression and its treatment
    Chantel Moret
    NeuroBiz Consulting and Communications, Les Grèzes, La Verdarié, 81100 Castres, France
    IDrugs 7:558-62. 2004
    ..Although further studies using larger sample populations are needed, it is becoming clear that genetic tools will be a major factor in improving diagnosis and optimizing the treatment of depressive disorders in the near future...
  7. doi request reprint Problems associated with long-term treatment with selective serotonin reuptake inhibitors
    C Moret
    NeuroBiz Consulting and Communication, Castres, France
    J Psychopharmacol 23:967-74. 2009
    ..This article is an overview of the more common adverse events, which are seen with non-acute treatment with the SSRIs...